Results 71 to 80 of about 1,253,674 (265)

Navigating Diagnostic Challenges in Pulmonary Aspergillosis: A Case Series Demonstrating the Synergy of Investigation Techniques [PDF]

open access: yesInternational Journal of Scientific Research in Dental and Medical Sciences
Aspergillosis encompasses a spectrum of diseases caused by Aspergillus species, with pulmonary aspergillosis being a significant concern due to its increasing incidence and impact on both immunocompromised and immunocompetent individuals.
Anooja Pulimoottil Mani, Anila Jose
doaj   +1 more source

COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment—A Retrospective Study

open access: yesJournal of Fungi, 2023
Background: The incidence and outcome of pulmonary aspergillosis in coronavirus disease (COVID-19) patients on extracorporeal membrane oxygenation (ECMO) are unknown and have not been fully addressed.
Ali Nuh   +7 more
doaj   +1 more source

Necrotizing pulmonary aspergillosis [PDF]

open access: yesThorax, 1970
Necrotizing or invasive aspergillary infection of the lungs has previously been considered a rare condition affecting only the debilitated or seriously ill. Four patients with necrotizing pulmonary aspergillosis are described, and the mycological and histopathological findings are discussed.
W P, Kennedy, D N, Malone, W, Blyth
openaire   +2 more sources

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis

open access: yes, 1995
Invasive pulmonary aspergillosis is a frequent complication in immunocompromised patients. The role of the prolonged use of steroids in predisposing to invasive aspergillosis has been recognized, but exceptionally described in asthmatic patients.
Cazzadori, A.   +3 more
core   +1 more source

Surgery for pulmonary aspergillosis [PDF]

open access: yes, 1993
Surgery for pulmonary aspergillosis was evaluated in 20 patients who underwent surgery. These included pulmonary aspergillosis in 17, bronchial aspergillosis in 2 and pleural aspergillosis in 1, respectively.
Nagayasu, Takeshi   +8 more
core   +1 more source

IL‐33 Drives Inflammatory Changes and Extracellular Trap Formation in Eosinophils Involving Oxidised LDL and Complement Pathways

open access: yesAllergy, EarlyView.
IL‐33 induces inflammatory gene signatures in eosinophils, characterised by the upregulation of cell surface markers, inflammatory mediators and regulatory factors, all of which were also observed in nasal polyp‐derived eosinophils. Ox‐LDL and complement fragments (C3a and C5a) promote eosinophil adhesion and survival.
Emiko Matsuyama   +16 more
wiley   +1 more source

Advances in the diagnosis and management of pulmonary aspergillosis

open access: yes, 2020
Aspergillus is a mould that is ubiquitous in nature and may lead to a variety of infectious and allergic diseases depending on the host's immune status or pulmonary structure.
Gao, Yuqing; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, USA   +1 more
core   +1 more source

Invasive Aspergillus tracheobronchitis in a patient with hairy cell leukemia and previous Plasmodium falciparum infection

open access: yesMonaldi Archives for Chest Disease, 2019
Invasive Aspergillus tracheobronchitis is a relatively rare form of invasive pulmonary aspergillosis characterized by invasion of the tracheobronchial tree by Aspergillus spp.
Elvira-Markella Antonogiannaki   +4 more
doaj   +1 more source

Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade

open access: yesAllergy, EarlyView.
Studies suggest that type 2 inflammatory diseases are driven by overactivation of the IL4/IL13 pathway, manifesting differently in distinct tissues. We performed quantitative analyses using several large independent datasets to explore the interrelation of type 2 inflammatory diseases based on co‐prevalence, genetic predispositions, and transcriptomic ...
Jennifer D. Hamilton   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy